1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2014

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2014" provides data on the Type 1 Diabetes (Juvenile Diabetes) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type 1 Diabetes (Juvenile Diabetes). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type 1 Diabetes (Juvenile Diabetes). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Type 1 Diabetes (Juvenile Diabetes) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Type 1 Diabetes (Juvenile Diabetes) 25
Subjects Recruited Over a Period of Time 33
Clinical Trials by Sponsor Type 34
Prominent Sponsors 35
Top Companies Participating in Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials 36
Prominent Drugs 38
Latest Clinical Trials News on Type 1 Diabetes (Juvenile Diabetes) 39
Apr 14, 2014: LX4211 Achieves Positive Results In Type 1 Diabetes Clinical Trial 39
Apr 09, 2014: Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone Lispro 39
Mar 31, 2014: Halozyme Announces that Consistent 1 Trial Of Hylenex Recombinant Met Primary Endpoint 41
Mar 27, 2014: Oramed Pharmaceuticals Announces First Patient Enrolled in a US Phase 2a Trial for ORMD-0801 in Treatment of Type 1 Diabetes 42
Mar 20, 2014: Adocia confirms positive clinical results for its BioChaperone Combo, a combination of long-acting insulin glargine and fast-acting insulin lispro 42
Mar 10, 2014: Fibrotech announces positive Phase Ia results for anti-fibrotic FT011 43
Mar 05, 2014: Kamada Initiates Phase 2/3 Clinical Trial of Glassia to Treat Newly Diagnosed Pediatric Patients with Type 1 Diabetes 44
Mar 04, 2014: Novo Nordisk Successfully Completes Phase I Trial of its Proprietary Oral Insulin using Merrion Pharmaceuticals' GIPET Technology. 45
Feb 27, 2014: Adocia Announces Preliminary Positive Clinical Results for its Combination of Long-Acting Insulin Glargine and Fast-acting Insulin Analog Lispro, BioChaperone Combo 45
Clinical Trial Profiles 47
Clinical Trial Overview of Top Companies 47
Novo A/S 47
Clinical Trial Overview of Novo A/S 47
Sanofi 60
Clinical Trial Overview of Sanofi 60
Eli Lilly and Company 64
Clinical Trial Overview of Eli Lilly and Company 64
Pfizer Inc. 67
Clinical Trial Overview of Pfizer Inc. 67
Bristol-Myers Squibb Company 69
Clinical Trial Overview of Bristol-Myers Squibb Company 69
MannKind Corporation 71
Clinical Trial Overview of MannKind Corporation 71
Steno Diabetes Center A/S 73
Clinical Trial Overview of Steno Diabetes Center A/S 73
Biodel Inc. 74
Clinical Trial Overview of Biodel Inc. 74
Medtronic, Inc. 76
Clinical Trial Overview of Medtronic, Inc. 76
GlaxoSmithKline plc 77
Clinical Trial Overview of GlaxoSmithKline plc 77
Clinical Trial Overview of Top Institutes / Government 78
The National Institute of Diabetes and Digestive and Kidney Diseases 78
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 78
The National Institute of Allergy and Infectious Diseases 80
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 80
The Medical University of Graz 82
Clinical Trial Overview of The Medical University of Graz 82
Baylor College of Medicine 83
Clinical Trial Overview of Baylor College of Medicine 83
Yale University 84
Clinical Trial Overview of Yale University 84
University of Virginia 85
Clinical Trial Overview of University of Virginia 85
University of Colorado 86
Clinical Trial Overview of University of Colorado 86
Rabin Medical Center 87
Clinical Trial Overview of Rabin Medical Center 87
Massachusetts General Hospital 88
Clinical Trial Overview of Massachusetts General Hospital 88
University of Minnesota 89
Clinical Trial Overview of University of Minnesota 89
Five Key Clinical Profiles 90
Appendix 196
Abbreviations 196
Definitions 196
Research Methodology 197
Secondary Research 197
About GlobalData 198
Contact Us 198
Disclaimer 198
Source 198

List of Tables
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 33
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 34
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 35
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 37
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2014* 47
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 60
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 64
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 67
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 69
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2014* 71
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Steno Diabetes Center A/S, 2014* 73
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biodel Inc., 2014* 74
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2014* 76
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 77
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 78
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 80
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2014* 82
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014* 83
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 84
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014* 85
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2014* 86
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2014* 87
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 88
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 89

List of Figures
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 33
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 34
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 35
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
GlobalData Methodology 197

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.